COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $500,000 | -49.5% | 500,000 | 0.0% | 0.06% | -44.4% |
| Q1 2024 | $990,000 | +26.9% | 500,000 | 0.0% | 0.12% | -15.2% |
| Q4 2023 | $780,000 | -67.7% | 500,000 | -59.2% | 0.14% | -86.3% |
| Q3 2023 | $2,415,500 | -61.4% | 1,226,142 | -37.7% | 1.01% | -32.5% |
| Q2 2023 | $6,262,361 | -12.0% | 1,969,296 | -9.5% | 1.50% | -23.9% |
| Q1 2023 | $7,118,927 | -36.5% | 2,177,042 | -2.4% | 1.96% | -59.3% |
| Q4 2022 | $11,219,000 | +300.0% | 2,230,441 | +81.3% | 4.83% | +364.3% |
| Q3 2022 | $2,805,000 | -14.0% | 1,230,441 | 0.0% | 1.04% | -12.4% |
| Q2 2022 | $3,261,000 | +87.4% | 1,230,441 | -3.1% | 1.19% | +135.5% |
| Q1 2022 | $1,740,000 | -72.6% | 1,270,211 | -36.5% | 0.50% | -67.8% |
| Q4 2021 | $6,340,000 | – | 2,000,000 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 2,829,712 | $2,829,712 | 0.79% |
| MPM BioImpact LLC | 5,005,086 | $5,005,086 | 0.78% |
| Orbimed Advisors | 22,362,850 | $22,362,850 | 0.44% |
| Vivo Capital, LLC | 3,556,023 | $3,556,023 | 0.33% |
| CM Management, LLC | 310,000 | $310,000 | 0.28% |
| CAXTON CORP | 43,465 | $43,465 | 0.22% |
| Rock Springs Capital Management LP | 5,513,788 | $5,513,788 | 0.17% |
| Cormorant Asset Management, LP | 2,030,823 | $2,030,823 | 0.12% |
| Ground Swell Capital, LLC | 124,394 | $124,394 | 0.10% |
| Monashee Investment Management LLC | 500,000 | $500,000 | 0.06% |